Atai Life Sciences (ATAI) Founder Christian Angermayer Interview.(VIDEO)
Best Psychedelic related interview we've seen yet. Christian states, "I think ultimately, the total addressable market is 100% of the world population!"
Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?
Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found...
Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.
Here's How Provention's Treatment Works.
Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...
Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...
Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...
Initiating Coverage on Psycheceutical BioScience (BWVI).
"Imagine Applying a Psychedelic Topically, Receiving the Benefits...
Tsunami of Business Headed Pressure Bio’s (PBIO) Way?
We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond....
Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.
13D Filing on AYTU (As of the date hereof, each of the Reporting Persons may be deemed to be the beneficial owner...
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
Tharimmune (THAR) Announces Positive Topline “Itching” Data.
Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Chronic Liver Disease Patients
Phase...
Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.
Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.